Literature DB >> 23698466

Tid1-L inhibits EGFR signaling in lung adenocarcinoma by enhancing EGFR Ubiquitinylation and degradation.

Chi-Yuan Chen1, Chia-Ing Jan, Jeng-Fan Lo, Shuenn-Chen Yang, Yih-Leong Chang, Szu-Hua Pan, Wen-Lung Wang, Tse-Ming Hong, Pan-Chyr Yang.   

Abstract

Tid1 (DNAJA3), a DnaJ cochaperone, may promote degradation of oncogenic kinases. Tid1 has 2 isoforms, Tid1-L and Tid1-S, that may function differently. In this study, we investigated the role of the Tid1 isoforms in regulating EGF receptor (EGFR) signaling and lung cancer progression. We found that both Tid1-L and Tid1-S expressions were reduced in patients with non-small cell lung cancer compared with normal counterparts. Tid1-L expression correlated inversely with EGFR expression. Low Tid1-L/high EGFR expression predicted poor overall survival in patients with lung adenocarcinoma. Tid1-L overexpression in lung cancer cells attenuated EGFR signaling and inhibited cell proliferation, colony formation, and tumor growth in subcutaneous and orthotropic xenograft models. Conversely, depletion of Tid1 restored EGFR signaling and increased cell proliferation and colony formation. Tid1-L, but not Tid1-S, interacted with EGFR/HSP70/HSP90 through the DnaJ domain, counteracting the EGFR regulatory function of HSP90 by causing EGFR ubiquitinylation and proteasomal degradation. Tid1-L inhibited EGFR signaling even more than the HSP90 inhibitor 17-allylamino-demethoxy geldanamycin. We concluded that Tid1-L acted as a tumor suppressor by inhibiting EGFR signaling through interaction with EGFR/HSP70/HSP90 and enhancing EGFR ubiquitinylation and degradation. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698466     DOI: 10.1158/0008-5472.CAN-12-4066

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Tid1, the Mammalian Homologue of Drosophila Tumor Suppressor Tid56, Mediates Macroautophagy by Interacting with Beclin1-containing Autophagy Protein Complex.

Authors:  Ge Niu; Huan Zhang; Dan Liu; Li Chen; Chandra Belani; Hong-Gang Wang; Hua Cheng
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

2.  CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.

Authors:  Wen Peng; Shuang Shi; Jiacheng Zhong; Hanghua Liang; Jianbin Hou; Xiaosong Hu; Feng Wang; Jiayi Zhang; Shengjun Geng; Xiaochuan Sun; Dong Zhong; Hongjuan Cui
Journal:  Oncogene       Date:  2022-04-22       Impact factor: 9.867

Review 3.  Putting human Tid-1 in context: an insight into its role in the cell and in different disease states.

Authors:  Sagarika Banerjee; Rupesh Chaturvedi; Anu Singh; Hemant R Kushwaha
Journal:  Cell Commun Signal       Date:  2022-07-19       Impact factor: 7.525

Review 4.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.

Authors:  C-H Chen; W-H Chang; K-Y Su; W-H Ku; G-C Chang; Q-S Hong; Y-J Hsiao; H-C Chen; H-Y Chen; R Wu; P-C Yang; J J W Chen; S-L Yu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

6.  DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1.

Authors:  Hye-Youn Kim; Young-Mi Kim; Suntaek Hong
Journal:  Cell Death Dis       Date:  2021-05-08       Impact factor: 8.469

7.  Sulforaphane attenuates EGFR signaling in NSCLC cells.

Authors:  Chi-Yuan Chen; Zhu-Yun Yu; Yen-Shu Chuang; Rui-Mei Huang; Tzu-Chien V Wang
Journal:  J Biomed Sci       Date:  2015-06-03       Impact factor: 8.410

8.  DNAJA1 promotes cancer metastasis through interaction with mutant p53.

Authors:  Atsushi Kaida; Satomi Yamamoto; Alejandro Parrales; Eric D Young; Atul Ranjan; Mohamed A Alalem; Kei-Ichi Morita; Yu Oikawa; Hiroyuki Harada; Tohru Ikeda; Sufi M Thomas; Francisco J Diaz; Tomoo Iwakuma
Journal:  Oncogene       Date:  2021-06-28       Impact factor: 9.867

9.  The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.

Authors:  Chi-Yuan Chen; Shuenn-Chen Yang; Kuo-Hsiung Lee; Xiaoming Yang; Lin-Yi Wei; Lu-Ping Chow; Tzu-Chien V Wang; Tse-Ming Hong; Jau-Chen Lin; Crysline Kuan; Pan-Chyr Yang
Journal:  J Med Chem       Date:  2014-01-31       Impact factor: 7.446

10.  Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation.

Authors:  Ding Qu; Junjie He; Congyan Liu; Jing Zhou; Yan Chen
Journal:  Int J Nanomedicine       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.